Laura Shaughnessy
Papers
1
Total Citations
4
H-Index
1
About
Dr. Laura Shaughnessy is a clinical researcher whose work focuses on gastroenterology, specifically gastroparesis and the therapeutic potential of ghrelin agonists. Her most cited study, the Phase 2 trial of TZP-102, established a critical link between symptom relief—including nausea, early satiety, bloating, and abdominal pain—and patients’ overall rating of treatment effect. This work provided early evidence that ghrelin receptor activation could address the debilitating symptoms of gastroparesis, a condition with limited treatment options. Though her citation count is modest, Shaughnessy’s contribution is notable for its patient-centered approach, correlating objective symptom improvement with subjective patient experience. Her research has informed subsequent investigations into ghrelin-based therapies, highlighting the importance of aligning clinical endpoints with patient-reported outcomes. Shaughnessy’s work remains a foundational reference for researchers exploring novel pharmacologic interventions in neurogastroenterology.
Research Focus
Key Achievements
Top Papers
- 1